Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Hold/Sell

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$144.30
Market Cap
7.86B
Sector
Health Care
Div. Growth
-
P/E
257.9
P/B
7.15
P/S
26.01
Dividend %
-
P/CF
22.8
P/FCF
172.2
Op. Cash Flow
65.9K
FCF
0.8
Op. Margin
13.10%
Net Margin
10.20%
ROE
2.90%
ROI
2.00%
ROA
2.20%
EPS Growth
-0.50%
Current Ratio
13.3
Debt/Equity
22.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Navidea Biopharmaceuticals Inc (NAVB) $2.73 - - 70.1M Strong Buy
Titan Pharmaceuticals, Inc. (TTNP) $0.21 - - 23M Strong Buy
Dynasil Corporation of America (DYSL) $0.84 - - 13.5M Strong Buy
Allied Healthcare Products Inc (AHPI) $5.70 - - 28.6M Strong Buy
Tivity Health Inc (TVTY) $13.77 - - 783.8M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More